QQ客服 官方微博 反馈留言

	Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents
	Chen, Minfeng[1,2]; Lei, Xueping[1,2]; Shi, Changzheng[3]; Huang, Maohua[1,2]; Li, Xiaobo[1,2]; Wu, Baojian[1,2]; Li, Zhengqiu[1,2]; Han, Weili[4]; Du, Bin[3]; Hu, Jianyang[1,2]
刊名	JOURNAL OF CLINICAL INVESTIGATION
	2017
卷号	127页码:3689-3701
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2186953
专题	华南理工大学
作者单位	1.[1]Jinan Univ, Coll Pharm, 601 West Huangpu Rd, Guangzhou 510632, Guangdong, Peoples R China 2.[2]Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituent, Guangzhou, Guangdong, Peoples R China 3.[3]Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China 4.[4]Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China 5.[5]Jinan Univ, Analyt & Testing Ctr, Guangzhou, Guangdong, Peoples R China 6.[6]Guangzhou Med Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China 7.[7]Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore
推荐引用方式 GB/T 7714	Chen, Minfeng[1,2],Lei, Xueping[1,2],Shi, Changzheng[3],et al. Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents[J]. JOURNAL OF CLINICAL INVESTIGATION,2017,127:3689-3701.
APA	Chen, Minfeng[1,2].,Lei, Xueping[1,2].,Shi, Changzheng[3].,Huang, Maohua[1,2].,Li, Xiaobo[1,2].,...&Ye, Wencai[1,2].(2017).Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents.JOURNAL OF CLINICAL INVESTIGATION,127,3689-3701.
MLA	Chen, Minfeng[1,2],et al."Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents".JOURNAL OF CLINICAL INVESTIGATION 127(2017):3689-3701.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。